Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA) (NeuREHA)

June 15, 2023 updated by: Yannick Bleyenheuft, Université Catholique de Louvain

Implementation of a HABIT-ILE Intervention at William Lennox Neurological : a Randomized Controlled Trial

Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of children with acquired brain injury.

Study Overview

Detailed Description

The aim is to investigate, for the first time, the effectiveness of HABIT-ILE therapy in a hospital setting in the treatment of a population representative of the clinical population with children with acquired brain injuries.

The hypothesis is that an in-hospital HABIT-ILE protocol will be more effective than conventional therapies usually given to children with acquired brain injury, and that this difference will be objectively demonstrated by clinical assessments of motor function, cognition and participation conducted before and after treatment periods.

The aim of the study is therefore to evaluate the effect of intensive bimanual hand-arm therapy including the lower extremities (HABIT-ILE) on body functions and structures, activity and participation in children with acquired brain injury.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Brussels, Belgium, 1200
      • Bruxelles, Belgium
        • Recruiting
        • Spontaneous contact via doctors or other partners
        • Contact:
    • Brabant-Wallon
      • Ottignies-Louvain-la-Neuve, Brabant-Wallon, Belgium, 1340
        • Recruiting
        • Centre Hospitalier Neurologique William Lennox
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • children with acquired brain injury of school
  • age 5 to 18 years inclusive

Exclusion Criteria:

  • Unstable seizure
  • programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time
  • Severe visual or cognitive impairments likely to interfere with intervention or testing session completion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional intervention
Conventional physical and occupational therapy
2 weeks usual intervention (waitlist group)
Experimental: HABIT-ILE
Hand and arm bimanuel intensive therapy including lowers extremities
2 weeks HABIT-ILE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Gross Motor Function Measurement (GMFM 66)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
The GMFM has been developed to measure the change in gross motor function over time in children with cerebral palsy.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Flanker task
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Cognitive functions of the children will be assessed by Flanker task.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in isometric muscular strength (Jamar)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
A quantitative and objective measure of isometric muscular strength of hand and forearm.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in unimanual dexterity: Box and Blocks test (BBT)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
The BBT is a test of gross manual dexterity. Each hand is tested individually and the BBT is scored through the number of blocks carried over the partition from one part to another part of a box during the one-minute trial period.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes on bimanual function (Assisting Hand Assessment (AHA))
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Developed to observe the efficacy of the assisting hand use, in children with unilateral cerebral palsy (scored in percentage), during bimanual activities for the randomized controlled trial
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in 6 Minutes Walking Test (6MWT)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
The 6 Minutes Walking Test measures the distance that the patient walk as much as possible within a period of 6-minutes in a 30 meters long corridor.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in Pediatric balance scale (PBS)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
A 14-item criterion-referencekd measure that examines functional balance in the context of everyday tasks in the pediatric population.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in Canadian Occupational Performance Measure (COPM)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
This is an interview-setting designed to capture a patient's self-perception of performance and satisfaction of it in everyday activities, observed over time. During the interview, parents set up 5 activities considered difficult in daily life. These are then assessed, in a 1 to 10 scale, regarding the child's self-perception of performance and satisfaction of it. The total score is the average of the scores for perception and satisfaction separately (score from 1 to 10; higher score means better performance/satisfaction)
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in ACTIVLIM-CP questionnaire
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
This parent's filled questionnaire measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower extremities through 43 items specific to patients with cerebral palsy. It ranges from - 7 to +7 logits (higher score means better performance).
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
The PEDI-CAT is the new version of the Pediatric Evaluation of Disability Inventory (PEDI). The PEDI-CAT is comprised of 276 functional activities acquired throughout infancy, childhood and young adulthood. Based on the nternational Classification of Functioning, Disability and Health for Children and Youth (ICF-CY) model, the PEDI-CAT contents provide information about the activities and participation component. It ranges from 0 to 100% (higher score means better performance).
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in Pediatric quality of life inventory (PedsQL)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
The Pediatric Quality of Life Inventory is a brief measure of health-related quality of life in children and young people. The measure can be completed by parents (the Proxy Report) as well as children and young people (the Self-Report).
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Changes in Measure of Processes of Care (MPOC-20)
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)

Assesses the parents' perceptions of the care they and their children receive from children's rehabilitation treatment centres. Using a 8-point response scale, parents answer to 20 questions, indicating to what extent they have experienced the events or the situations described. A score of 7 means that they have experienced this aspect to a very great extent, or most of the time. A score of 1 means that they have not experienced this aspect at all. A score of 0 means that the question does not apply to them.

There is no total score. However, because the statements are positively worded, higher total scores indicates that needs of the parents are being met to a great extent.

T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Status in Wechsler Intelligence Scale for Children-Non verbal short version (WISC)
Time Frame: T0 (baseline)
This is a validated assessment for children aged 4 and over, with subtests such as object assembly, recognition, picture arrangement and fluid reasoning. The brief 15-20 minute version will be used. Scores are given for the full battery and for the subtests (subtest T-scores and percentile ranks).
T0 (baseline)
Classification du niveau moteur: The Gross Motor Function Classification System - Expanded & Revised (GMFCS - E&R)
Time Frame: T0 (baseline)
The Gross Motor Function Classification System - Expanded & Revised (GMFCS - E&R) is a 5-level classification system that describes the gross motor function of children and youth on the basis of their self-initiated movement with particular emphasis on sitting, walking, and wheeled mobility.
T0 (baseline)
QUALITY OF LIFE : KIDSCREEN 10
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
The Gross Motor Function Classification System - Expanded & Revised (GMFCS - E&R)
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Stroop task
Time Frame: T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)
Executive functions of the children will be assessed by Stroop task.
T0 (baseline), T1 (after 2weeks intervention), T2(3 months follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yannick Bleyenheuft, Professor, Insititue of Neurosciences, UCLouvain

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2023

Primary Completion (Estimated)

December 20, 2024

Study Completion (Estimated)

June 10, 2028

Study Registration Dates

First Submitted

June 2, 2023

First Submitted That Met QC Criteria

June 2, 2023

First Posted (Actual)

June 13, 2023

Study Record Updates

Last Update Posted (Estimated)

June 19, 2023

Last Update Submitted That Met QC Criteria

June 15, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acquired Brain Injury

Clinical Trials on HABIT-ILE

Subscribe